Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | ACR | P10323 | 1/20 | 0.44 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11418447 | 1.00 | CYP2C9 (0.60) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL10909504 | 0.96 | CYP2C9 (0.56) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL10910735 | 0.96 | CYP2C9 (0.56) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL10909503 | 0.96 | CYP2C9 (0.56) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL10909500 | 0.96 | CYP2C9 (0.56) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL10910739 | 0.96 | CYP2C9 (0.56) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL10898816 | 0.95 | CYP2C9 (0.66) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL10938649 | 0.95 | CYP2C9 (0.66) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL11408041 | 0.93 | CYP2C9 (0.51) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL11408469 | 0.92 | CYP2C9 (0.50) | CYP2C9MAPTALDH1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3345939-B1 | POWDER MIXTURE | DAINIPPON INK & CHEMICALS (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-10581022-B2 | Polymerizable liquid crystal compound, composition, liquid crystal polymerization film-kind thereof and use thereof | JNC CORPORATION (JP) | 2020-03-03 | — | — | US | disclosed |
| EP-3345939-A1 | POWDER MIXTURE | DIC Corporation (JP) | 2018-07-11 | — | — | EP | disclosed |
| US-20170174992-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, COMPOSITION, LIQUID CRYSTAL POLYMERIZATION FILM-KIND THEREOF AND USE THEREOF | JNC CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
| US-9540567-B2 | Polymerizable liquid crystal composition and optically anisotropic body | JNC CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20160289562-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND OPTICALLY ANISOTROPIC BODY | JNC CORPORATION (JP) | 2016-10-06 | — | — | US | disclosed |
| US-7923078-B2 | Light-modulating liquid-crystal element | ADEKA CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-20090279043-A1 | LIGHT-MODULATING LIQUID-CRYSTAL ELEMENT | ADEKA CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10581022-B2 | Polymerizable liquid crystal compound, composition, liquid crystal polymerization film-kind thereof and use thereof | RCC1, CHRM1, PFN1 | CYP2C9 2312/4885MAPT 862/4885ALDH1A1 2853/4885 |
| US-20170174992-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, COMPOSITION, LIQUID CRYSTAL POLYMERIZATION FILM-KIND THEREOF AND USE THEREOF | RCC1, CHRM1, PFN1 | CYP2C9 2312/4885MAPT 862/4885ALDH1A1 2853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.